Lima Memorial Health System Logo
Approximate ER WAIT TIME WAIT TIME MACRO

Health Library

Minimal change disease
     
Print-Friendly
Bookmarks

Minimal change disease

Minimal change nephrotic syndrome; Nil disease; Lipoid nephrosis; Idiopathic nephrotic syndrome of childhood

 

Minimal change disease is a kidney disorder that can lead to nephrotic syndrome. Nephrotic syndrome is a group of symptoms that include protein in the urine, low blood protein levels in the blood, high cholesterol levels, high triglyceride levels, and swelling.

Causes

 

Each kidney is made of more than a million units called nephrons, which filter blood and produce urine.

Minimal change disease is due to damage to the glomeruli. These are the tiny blood vessels inside the nephron where blood is filtered to make urine and waste is removed. The condition gets its name because this damage is not visible under a regular microscope. It can only be seen under a very powerful microscope called an electron microscope.

Minimal change disease is the most common cause of nephrotic syndrome in children. It is also seen in adults with nephrotic syndrome, but is less common.

The cause is unknown, but the condition may occur after or be related to:

  • Allergic reactions
  • Use of non-steroidal anti-inflammatory drugs (NSAIDs)
  • Tumors
  • Vaccinations (flu and pneumococcal, though rare)
  • Viral infections

 

Symptoms

 

There may be symptoms of nephrotic syndrome, including:

  • Foamy appearance of the urine
  • Poor appetite
  • Swelling (especially around the eyes, feet and ankles, and in the abdomen)
  • Weight gain (from fluid retention)

Minimal change disease does not reduce the amount of urine produced. It rarely progresses to kidney failure.

 

Exams and Tests

 

Your health care provider may not be able to see any signs of the disease, other than swelling. Blood and urine tests reveal signs of nephrotic syndrome, including:

  • High level of cholesterol in the blood
  • High levels of protein in the urine
  • Low levels of albumin in the blood

A kidney biopsy and examination of the tissue with an electron microscope can show signs of minimal change disease.

 

Treatment

 

Medicines called corticosteroids (or steroids) can cure minimal change disease in most children. Some children may need to stay on steroids to keep the disease from returning.

Steroids are very effective in children, but are less often effective in adults. Adults may have more frequent relapses and become dependent on steroids.

If steroids are not effective, your provider will likely suggest other medicines.

Swelling may be treated with:

  • ACE inhibitor medicines
  • Blood pressure control
  • Diuretics (water pills)

You may also be told to reduce the amount of salt in your diet.

 

Outlook (Prognosis)

 

Children usually respond better to corticosteroids than adults. Children often respond within the first month of treatment.

A relapse can occur. The condition may improve after long-term treatment with corticosteroids and medicines that suppress the immune system (immunosuppressants).

 

When to Contact a Medical Professional

 

Contact your provider if:

  • You develop symptoms of minimal change disease
  • You have this condition and your symptoms get worse
  • You develop new symptoms, including side effects from the medicines used to treat the disorder

 

 

References

Erkan E. Nephrotic syndrome. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 567.

Saha MK, Pendergraft WF, Jennette JC, Falk RJ. Primary glomerular disease. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 31.

BACK TO TOPText only

 
  • Glomerulus and nephron

    Glomerulus and nephron

    illustration

    • Glomerulus and nephron

      Glomerulus and nephron

      illustration

    A Closer Look

     

      Talking to your MD

       

        Self Care

         

          Tests for Minimal change disease

           
             

            Review Date: 10/23/2025

            Reviewed By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

            The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

            © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

            All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.
            © 1997- adam.comAll rights reserved.